BioSpace News Archive

Business

AnaptysBio Announces Third Quarter 2022 Financial Results and Provides Pipeline Update

AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported operating results for the third quarter ended September 30, 2022 and provided pipeline updates.

November 8, 2022
·
10 min read
Business

Aadi Bioscience Announces Planned Leadership Transition - November 08, 2022

Aadi Bioscience, Inc. announced the appointment of Neil Desai, Founder, President and CEO to Executive Chairman and Brendan Delaney, Chief Operating Officer, to President and CEO, effective as of January 1, 2023.

November 8, 2022
·
6 min read
Alkermes to Participate in the Stifel Healthcare Conference

Alkermes plc announced that management will participate in a fireside chat at the Stifel 2022 Healthcare Conference on Tuesday, Nov. 15, 2022 at 8:00 a.m. ET.

November 8, 2022
·
1 min read
Business

Halozyme Reports Third Quarter 2022 Financial and Operating Results

Halozyme Therapeutics, Inc. reported its financial and operating results for the third quarter ended September 30, 2022 and provided an update on its recent corporate activities and outlook.

November 8, 2022
·
21 min read
Biotech Beach

Neurocrine Biosciences to Present at Upcoming Healthcare Conferences - November 08, 2022

Neurocrine Biosciences, Inc. announced that members of the management team will participate at the following investor conferences.

November 8, 2022
·
1 min read
Business

Novavax Reports Third Quarter 2022 Financial Results and Operational Highlights

Novavax, Inc. (NASDAQ: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced its financial results and operational highlights for the third quarter ended September 30, 2022.

November 8, 2022
·
14 min read
Business

Berkeley Lights Reports Third Quarter 2022 Financial Results

Berkeley Lights, Inc., a leader in digital cell biology, reported financial results for the quarter ended September 30, 2022.

November 8, 2022
·
7 min read
Business

Avidity Biosciences Reports Third Quarter 2022 Financial Results and Recent Highlights

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced financial results for the third quarter ended September 30, 2022 and highlighted recent corporate progress.

November 8, 2022
·
10 min read
Business

Cumberland Pharmaceuticals Reports 41% Revenue Growth

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, announced that its product portfolio of FDA-approved brands delivered combined revenues of $11.4 million during the third quarter of 2022 - a 41% increase over the prior year period.

November 8, 2022
·
23 min read
Biotech Beach

Viking Therapeutics to Present at Stifel 2022 Healthcare Conference

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation as part of the Stifel 2022 Healthcare Conference.

November 8, 2022
·
2 min read